Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

DAVID MEREDITH

Allopathic & Osteopathic Physicians Family Medicine

NPI
1427041383
CMS profile
110131
Location
GONZALES, TX

General Payments · PY2018–2024

$4,301.69

  • Reported across 282 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$694.25

37 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $694.25 37

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $761.65 53
PY2019 $466.77 33
PY2020 $411.46 29
PY2021 $713.37 43
PY2022 $472.89 29
PY2023 $781.30 58
PY2024 $694.25 37

Payment records · PY2024 (37)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $14.07 02/19/2024 Food and Beverage Undisputed 01/23/2026 1111650614 CMS
AstraZeneca Pharmaceuticals LP $129.30 01/10/2024 Food and Beverage Undisputed 01/23/2026 1105863248 CMS
AstraZeneca Pharmaceuticals LP $14.85 08/16/2024 Food and Beverage Undisputed 01/23/2026 1105900262 CMS
AstraZeneca Pharmaceuticals LP $13.21 10/11/2024 Food and Beverage Undisputed 01/23/2026 1105814605 CMS
AstraZeneca Pharmaceuticals LP $13.16 11/08/2024 Food and Beverage Undisputed 01/23/2026 1104666073 CMS
Novartis Pharmaceuticals Corporation $27.82 02/22/2024 Food and Beverage Undisputed 01/23/2026 1087131028 CMS
Novartis Pharmaceuticals Corporation $55.88 07/16/2024 Food and Beverage Undisputed 01/23/2026 1087131046 CMS
Novo Nordisk Inc $3.89 01/19/2024 Food and Beverage Undisputed 01/23/2026 1097559653 CMS
Novo Nordisk Inc $14.75 02/05/2024 Food and Beverage Undisputed 01/23/2026 1096915254 CMS
Novo Nordisk Inc $14.69 03/04/2024 Food and Beverage Undisputed 01/23/2026 1096574879 CMS
Novo Nordisk Inc $4.22 03/15/2024 Food and Beverage Undisputed 01/23/2026 1096958257 CMS
Novo Nordisk Inc $4.28 03/29/2024 Food and Beverage Undisputed 01/23/2026 1097765062 CMS
Novo Nordisk Inc $3.84 04/12/2024 Food and Beverage Undisputed 01/23/2026 1097339328 CMS
Novo Nordisk Inc $16.65 04/17/2024 Food and Beverage Undisputed 01/23/2026 1096986654 CMS
Novo Nordisk Inc $8.23 05/29/2024 Food and Beverage Undisputed 01/23/2026 1096895715 CMS
Novo Nordisk Inc $17.01 06/03/2024 Food and Beverage Undisputed 01/23/2026 1097074728 CMS
Novo Nordisk Inc $3.82 06/21/2024 Food and Beverage Undisputed 01/23/2026 1097145453 CMS
Novo Nordisk Inc $16.20 07/08/2024 Food and Beverage Undisputed 01/23/2026 1096640786 CMS
Novo Nordisk Inc $3.80 08/23/2024 Food and Beverage Undisputed 01/23/2026 1096900601 CMS
Novo Nordisk Inc $17.12 08/27/2024 Food and Beverage Undisputed 01/23/2026 1096889128 CMS
Novo Nordisk Inc $3.69 09/05/2024 Food and Beverage Undisputed 01/23/2026 1097027882 CMS
Novo Nordisk Inc $23.31 09/06/2024 Food and Beverage Undisputed 01/23/2026 1096705984 CMS
Novo Nordisk Inc $20.66 09/23/2024 Food and Beverage Undisputed 01/23/2026 1096933065 CMS
Novo Nordisk Inc $16.14 09/24/2024 Food and Beverage Undisputed 01/23/2026 1097116279 CMS
Novo Nordisk Inc $3.50 11/01/2024 Food and Beverage Undisputed 01/23/2026 1097710006 CMS
Novo Nordisk Inc $18.10 11/19/2024 Food and Beverage Undisputed 01/23/2026 1097090893 CMS
Organon Llc $20.00 03/06/2024 Food and Beverage Undisputed 01/23/2026 1136315523 CMS
Otsuka America Pharmaceutical, Inc. $18.88 11/18/2024 Food and Beverage Undisputed 01/23/2026 1118942193 CMS
Paratek Pharmaceuticals, Inc. $15.00 10/02/2024 Food and Beverage Undisputed 01/23/2026 1113910342 CMS
PFIZER INC. $27.30 05/14/2024 Food and Beverage Undisputed 01/23/2026 1131514601 CMS
PFIZER INC. $13.75 08/17/2024 Food and Beverage Undisputed 01/23/2026 1131872731 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $13.74 01/11/2024 Food and Beverage Undisputed 01/23/2026 1153734291 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $15.88 02/14/2024 Food and Beverage Undisputed 01/23/2026 1153632662 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $13.53 03/28/2024 Food and Beverage Undisputed 01/23/2026 1153426452 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $16.86 05/08/2024 Food and Beverage Undisputed 01/23/2026 1153673103 CMS
SANOFI PASTEUR INC. $39.17 01/31/2024 Food and Beverage Undisputed 01/23/2026 1128739502 CMS
SANOFI PASTEUR INC. $17.95 02/28/2024 Food and Beverage Undisputed 01/23/2026 1128739506 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.